Simvastatin Inhibits Glucose Metabolism and Legumain Activity in Human Myotubes

Simvastatin, a HMG-CoA reductase inhibitor, is prescribed worldwide to patients with hypercholesterolemia. Although simvastatin is well tolerated, side effects like myotoxicity are reported. The mechanism for statin-induced myotoxicity is still poorly understood. Reports have suggested impaired mito...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Robert, Solberg, Rigmor, Jacobsen, Linn Løkken, Voreland, Anette Larsen, Rustan, Arild Christian, Thoresen, G. Hege, Johansen, Harald Thidemann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3885717/
https://www.ncbi.nlm.nih.gov/pubmed/24416446
http://dx.doi.org/10.1371/journal.pone.0085721

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3885717/
https://www.ncbi.nlm.nih.gov/pubmed/24416446
http://dx.doi.org/10.1371/journal.pone.0085721

Ejemplares similares